Kilickap, S. Et Al. 2006. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. 30th Congress of the European-Society-for-Medical-Oncology , (İstanbul, Turkey), 202.

Kilickap, S., Yavuz, B., Aksoy, S., Sahiner, L., Harputluoglu, H., Dincer, M., ... Erman, M.(2006). Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma . 30th Congress of the European-Society-for-Medical-Oncology (pp.202). İstanbul, Turkey

Kilickap, Saadettin Et Al. "Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma," 30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 2006

Kilickap, Saadettin Et Al. "Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma." 30th Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, pp.202, 2006

Kilickap, S. Et Al. (2006) . "Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma." 30th Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, p.202.

@conferencepaper{conferencepaper, author={Saadettin Kilickap Et Al. }, title={Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma}, congress name={30th Congress of the European-Society-for-Medical-Oncology}, city={İstanbul}, country={Turkey}, year={2006}, pages={202} }